CD19 and acute lymphoblastic leukemia: To assess the functionality and specificity of CD19/NKG2DL tandem CAR T-cells in the presence and absence of CD19 antigen, we knocked-out the CD19 gene in the B-ALL cell line Nalm-6 (Figure 3A).